Outcomes of T3a Prostate Cancer with Unfavorable Prognostic Factors Treated with Brachytherapy Combined with External Radiotherapy and Hormone Therapy
Conclusions T3a prostate cancer with unfavorable prognostic factors presents not so optimistic outcome. Hormone therapy should be applied to prolong the biochemical progression-free or metastasis-free survival. The percentage of positive biopsy cores and the Gleason score are significant prognostic factors.
Source: Chinese Medical Sciences Journal - Category: Journals (General) Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | General Medicine | Hormonal Therapy | Hormones | Prostate Cancer | Study